Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Clinical Proteomics
|
December 3, 2010
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis
Xuefeng B Ling, Kenneth Lau, Chetan Deshpande, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2011
Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias
Kenneth Lau, Patrick Benitez, Alexandria Ardissone, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 12, 2010
The single kinin receptor signals to separate and independent physiological pathways in Malpighian tubules of the yellow fever mosquito
Stephen A Schepel, Andrew J Fox, Jeremy T Miyauchi, et al.
BMC Medicine
|
December 8, 2011
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses
Xuefeng B Ling, Kenneth Lau, John T Kanegaye, et al.
ACS Nano
|
September 18, 2023
Correction to "Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents"
Rajendran Jc Bose, Sukumar Uday Kumar, Yitian Zeng, et al.
ACS Nano
|
October 23, 2018
Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents
Rajendran J C Bose, Sukumar Uday Kumar, Yitian Zeng, et al.
Proteomics
|
December 8, 2010
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications
Xuefeng B Ling, Jane L Park, Tanya Carroll, et al.
Blood
|
March 3, 2016
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma
Rachid C Baz, Thomas G Martin, Hui-Yi Lin, et al.
Cancer
|
July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma
Ajai Chari, Myo Htut, Jeffrey A Zonder, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 15, 2020
Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
Hua Zhang, Wei-Lun Tang, Azadeh Kheirolomoom, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Clinical Proteomics
|
December 3, 2010
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis
Xuefeng B Ling, Kenneth Lau, Chetan Deshpande, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 15, 2011
Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias
Kenneth Lau, Patrick Benitez, Alexandria Ardissone, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 12, 2010
The single kinin receptor signals to separate and independent physiological pathways in Malpighian tubules of the yellow fever mosquito
Stephen A Schepel, Andrew J Fox, Jeremy T Miyauchi, et al.
BMC Medicine
|
December 8, 2011
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses
Xuefeng B Ling, Kenneth Lau, John T Kanegaye, et al.
ACS Nano
|
September 18, 2023
Correction to "Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents"
Rajendran Jc Bose, Sukumar Uday Kumar, Yitian Zeng, et al.
ACS Nano
|
October 23, 2018
Tumor Cell-Derived Extracellular Vesicle-Coated Nanocarriers: An Efficient Theranostic Platform for the Cancer-Specific Delivery of Anti-miR-21 and Imaging Agents
Rajendran J C Bose, Sukumar Uday Kumar, Yitian Zeng, et al.
Proteomics
|
December 8, 2010
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications
Xuefeng B Ling, Jane L Park, Tanya Carroll, et al.
Blood
|
March 3, 2016
Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma
Rachid C Baz, Thomas G Martin, Hui-Yi Lin, et al.
Cancer
|
July 20, 2016
A phase 1 dose-escalation study of filanesib plus bortezomib and dexamethasone in patients with recurrent/refractory multiple myeloma
Ajai Chari, Myo Htut, Jeffrey A Zonder, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 15, 2020
Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy
Hua Zhang, Wei-Lun Tang, Azadeh Kheirolomoom, et al.
Page
of 5